rs587782170
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782286
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782533
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782699
|
|
GAT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs730881931
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs730881932
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs730881940
|
|
GA |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs748589398
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs754367349
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs786201909
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs786202563
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs786203945
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs876658644
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs876658652
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs876659874
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782702
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.
|
21537932 |
2011 |
rs387907159
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.
|
21990120 |
2012 |
rs267606999
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair.
|
23438602 |
2013 |
rs267606999
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
|
24141787 |
2014 |
rs267606999
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
|
28829762 |
2017 |
rs587781410
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
|
27621404 |
2016 |
rs1413872299
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |
rs587781287
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |
rs587781995
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |
rs587782528
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |